Achiko AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACHKF research report →
Price Chart
About the company
Achiko AG, established in 2018 and based in Zurich, Switzerland, focuses on pioneering diagnostic technologies for both Indonesian and international markets. Its flagship innovation is AptameX, a rapid diagnostic test that identifies the SARS-CoV-2 virus by utilizing DNA aptamers, distinguishing it from traditional antigen-based methods. The company also offers Teman Sehat, a mobile application serving as a check-in and digital health passport.
- CEO
- Wern-Yi Goh
- IPO
- 2021
- Employees
- 10
- HQ
- Zurich, CH
Get TickerSpark's AI analysis on ACHKF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $377.40K
- P/E
- -0.04
- PEG
- -0.00
- P/S
- 6.04
- P/B
- -0.08
- EV/EBITDA
- -0.34
- Div Yield
- 0.00%
- Gross Margin
- 37.35%
- Op Margin
- -13366.81%
- Net Margin
- -14913.18%
- ROE
- 215.86%
- ROIC
- 471.15%
Latest fiscal year · YoY change
- Revenue
- $62.51K-97.8%
- Gross Profit
- $23.34K-94.3%
- Op Income
- $-8,355,193
- Net Income
- $-9,321,779+33.7%
- EPS
- $-0.07+49.8%
- OCF Growth
- -8.7%
- FCF Growth
- -17.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.39
- RSI (14)
- 6
- Avg Volume
- 530
No earnings-call transcripts are available for ACHKF yet.
- Free Float
- 83.3%
- Shares Outstanding
- 145.15M
- Float Shares
- 120.93M
Our ACHKF coverage
Recent articles, reports, and earnings notes.
No research on ACHKF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ACHKF report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.